The integration of
Pharmacontrol Electronic (PCE) into the Mettler Toledo group
following last year's acquisition has been largely completed and
has resulted in "an expansion in the reach of its track-and-trace
technologies in Europe, the US and Asia," according to the
The expanded global access to PCE's systems comes as industry regulations surrounding counterfeiting are becoming increasingly stringent, according to Mettler Toledo.
"New directives on serialisation technologies are coming to fruition in the EU and in the US in the next two to four years, and more stringent standards are also expected in China and India," it said in a statement.
"PCE's serialisation technologies can help pharmaceutical manufacturers meet these regulations and combat the rise in counterfeit drugs."
Pharmaceutical manufacturers across the world now have access to a comprehensive range of quality assurance technologies, compliant with the latest industry regulations, from one source, as well as access to a wider global service network.